|
|
2022 Corporate Members
 |
 |
|
|
 |
 |
 |
 |
 |
 |  |
 |  |
 |  |
 | |
 |  |
 |
Adaptive Biotechnologies, Blueprint Medicines, Boehringer Ingelheim, Taiho Oncology
Aveo Oncology, Gilead, Karyopharm Therapeutics
Commercial support by these organizations does not influence the objectives of Northern New England Clinical Oncology Society
Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org
This website brought to you by:
